Literature DB >> 27127193

Testosterone Replacement Therapy: New Data on Efficacy and Cardiovascular Safety.

Robert A Kloner1,2.   

Abstract

Entities:  

Year:  2016        PMID： 27127193     DOI： 10.1177/1074248416646938

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN： 1074-2484            Impact factor:   2.457


× No keyword cloud information.
  5 in total

1.  GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.

Authors:  Javier Duran; Cesar Oyarce; Mario Pavez; Denisse Valladares; Carla Basualto-Alarcon; Daniel Lagos; Genaro Barrientos; Mayarling Francisca Troncoso; Cristian Ibarra; Manuel Estrada
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

Review 2.  Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?

Authors:  Abdulmaged Traish
Journal:  Investig Clin Urol       Date:  2016-11-07

3.  Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy.

Authors:  Javier Duran; Daniel Lagos; Mario Pavez; Mayarling F Troncoso; Sebastián Ramos; Genaro Barrientos; Cristian Ibarra; Sergio Lavandero; Manuel Estrada
Journal:  Front Pharmacol       Date:  2017-09-11       Impact factor: 5.810

Review 4.  Androgen-Regulated Cardiac Metabolism in Aging Men.

Authors:  Genaro Barrientos; Paola Llanos; Carla Basualto-Alarcón; Manuel Estrada
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-15       Impact factor: 5.555

5.  A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation.

Authors:  Andrew Morton; Michael Williams; Marlon Perera; Sachinka Ranasinghe; Patrick E Teloken; Marissa Williams; Eric Chung; Matthew J Roberts
Journal:  World J Mens Health       Date:  2020-07-30       Impact factor: 5.400
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.